Press
15. February 2022
Very Successful Exit for High-Tech Gründerfonds - Kerry acquires c-LEcta
This strategically compelling combination will accelerate Kerry’s innovation capabilities in enzyme engineering, fermentation and bio-process developmentThe global presence of Kerry Group plc in the food and pharmaceutical sectors givesc-LEcta access to additional marketsHigh-Tech Gründerfonds was the first seed investor of c-LEcta
High-Tech Gründerfonds (“HTGF”) sells its shares in c-LEcta after accompanying the company for 16 years. Kerry Group plc (“Kerry”), the global
Press
23. June 2021
Successful Exit for Creathor Ventures, High-Tech Gründerfonds, Bayern Kapital and KfW – PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader SIRION Biotech
SIRION Biotech, Martinsried near Munich, will continue to grow its leading position in viral vector technologies for cell and gene therapy as part of PerkinElmerThe addition of SIRION’s offerings will complement PerkinElmer’s Horizon Discovery portfolioIn 2007 High-Tech Gründerfonds, Creathor Ventures together with KfW and Bayern Kapital were the first seed investors of SIRION Biotech GmbHThe transaction is subject to regulatory approvals
Bonn, 23.06.2021 – High-Tech Gründerfonds,
Press
22. April 2021
High-tech and humanity - robotic assistance enters intensive care units
Intelligent, assistive robotics for early mobilization of critically illintensive care patients convinces investors. Fighting the shortage of nurses with cutting-edge technology.
Supporting nurses, accelerating recovery. Reactive Robotics employs its robotic assistance system to treat, among others, Covid-19 patients in intensive care units, to enable these patients in recovering faster. The company has now raised a mid-seven-figure sum in a financing round.
In addition to the existing
